Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
News
Events
Contact us
News
U.S. clinical trials begin for twice-yearly HIV prevention injection
10 June 2024
New data provide schizophrenia treatment insights into switching to UZEDY® extended-release injectable suspension from invega sustenna®
10 June 2024
SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population
17 May 2024
Injectable HIV medication is superior to oral medication for patients who frequently miss doses
17 May 2024
New cabotegravir formulations approved to help prevent HIV-1 infection in adults and adolescents
10 May 2024
Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).
26 April 2024
Unlocking innovative hydrogel treatments
26 April 2024
Long-acting oral combo for HIV maintains viral suppression at Week 24
19 April 2024
Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies
19 April 2024
Newer stories
Older Stories